Alyeska Investment Group
EOLS icon

Alyeska Investment Group’s Evolus EOLS Stock Holding History

Alyeska Investment Group’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-325,000
Closed -$2.99M – 628
2025
Q2 		$2.99M Buy
325,000
+100,000
+44% +$1.02M 0.01% 464
2025
Q1 		$2.71M Sell
225,000
-100,000
-31% -$1.31M 0.01% 403
2024
Q4 		$3.59M Hold
325,000
– – 0.01% 425
2024
Q3 		$5.26M Buy
325,000
+151,414
+87% +$2.12M 0.03% 347
2024
Q2 		$1.88M Buy
+173,586
New +$2.14M 0.01% 415
2020
Q3 		– Sell
-332,977
Closed -$1.76M – 504
2020
Q2 		$1.76M Buy
332,977
+36,652
+12% +$169K 0.03% 366
2020
Q1 		$1.23M Buy
+296,325
New +$2.51M 0.02% 282

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Alyeska Investment Group's EOLS Position: Q3 2025 in Review

Alyeska Investment Group sold out of Evolus (EOLS) in Q3 2025, closing a stake of 325,000 shares — an estimated $2.99M sold.

Alyeska Investment Group first reported a position in EOLS in Q1 2020 and held it in 7 quarters. The position peaked at $5.26M in Q3 2024. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Alyeska Investment Group reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 325,000 Evolus shares in Q3 2025, an estimated $2.99M.
  • Alyeska Investment Group first reported a position in Evolus in Q1 2020 and held it in 7 quarters.
  • Alyeska Investment Group's Evolus position peaked at $5.26M in Q3 2024.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.